COPD - Nationale VersorgungsLeitlinien

14. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: A guideline developers' handbook.
Edinburgh: SIGN; 2004 [cited: 2005 Aug 22]. Available from:
http://www.sign.ac.uk/guidelines/fulltext/50/index.html
15. Definition and diagnosis of pulmonary disease with special reference to chronic bronchitis and
emphysema. Report of an expert committee. WHO Tech Rep Ser 1961;213:14-9.
16. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions.
Ciba Guest Symposium report. Thorax 1959;14:286-99.
17. Konietzko N, Fabel H. Weißbuch Lunge 2005: Defizite, Zukunftsperspektiven, Forschungsansätze.
Die Lunge und ihre Erkrankungen: Zur Lage und Zukunft der Pneumologie in Deutschland. 3rd ed.
Stuttgart: Thieme Verlag; 2005.
18. Statistisches Bundesamt. Statistisches Jahrbuch. Jahrgänge 1968-1999. Stuttgart: Kohlhammer;
1999.
19. Murray CJ, Lopez AD. The global burden of disease, a comprehensive assessment of mortality and
disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard
University Press; 1996.
20. Lopez AD,Murray CC. The global burden of disease, 1990-2020. Nat Med 1998;4(11):1241-3.
21. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee
TA, Miravitlles M, Aldington S, Beasley R. Epidemiology and costs of chronic obstructive pulmonary
disease. Eur Respir J 2006;27(1):188-207.
22. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117 Suppl 2:S5-9.
23. Nowak D, Dietrich ES, Oberender P, Überla K, Reitberger U, Schlegel C, Albers F, Ruckdäschel S,
Welsch R. Krankheitskosten von COPD in Deutschland. Pneumologie 2004;58(12):837-44.
24. Rychlik R, Pfeil T, Daniel D, Pfeil B, Mast O, Thate-Waschke I, Lorenz J. Zur sozioökonomischen
Relevanz akuter Exacerbationen der chronischen Bronchitis in der Bundesrepublik Deutschland.
Dtsch Med Wochenschr 2001;126(13):353-9.
25. Celli BR, Cote CG, Marin JM, Casanova C, Montes de OM, Mendez RA, Pinto P, V, Cabral HJ. The
body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive
pulmonary disease. N Engl J Med 2004;350(10):1005-12.
26. Fletcher C,Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1(6077):1645-8.
27. Laurell CB,Erikson S. The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin
deficiency. Scand J Clin Lab Invest 1963;15:132-40.
28. Orie NG, Sluiter HJ, De Vries K, Tammerling K, Wikop J. The host factor in bronchitis. In: Orie NG,
Sluiter HJ, editors. Bronchitis, an international symposium Assen: Royal Vangorum; 1961. p. 43-59.
29. Todisco T, de Benedictis FM, Iannacci L, Baglioni S, Eslami A, Todisco E, Dottorini M. Mild
prematurity and respiratory functions. Eur J Pediatr 1993;152(1):55-8.
30. Morgan WJ. Maternal smoking and infant lung function. Further evidence for an in utero effect. Am J
Respir Crit Care Med 1998;158(3):689-90.
31. Stein CE, Kumaran K, Fall CH, Shaheen SO, Osmond C, Barker DJ. Relation of fetal growth to adult
lung function in south India. Thorax 1997;52(10):895-9.
32. Svanes C, Omenaas E, Heuch JM, Irgens LM, Gulsvik A. Birth characteristics and asthma symptoms
in young adults: results from a population-based cohort study in Norway. Eur Respir J
1998;12(6):1366-70.
© 2006
80